Cargando…
New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options
Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and n...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487200/ https://www.ncbi.nlm.nih.gov/pubmed/37685356 http://dx.doi.org/10.3390/diagnostics13172818 |
_version_ | 1785103183216902144 |
---|---|
author | Pergola, Valeria Mattesi, Giulia Cozza, Elena Pradegan, Nicola Tessari, Chiara Dellino, Carlo Maria Savo, Maria Teresa Amato, Filippo Cecere, Annagrazia Perazzolo Marra, Martina Tona, Francesco Guaricci, Andrea Igoren De Conti, Giorgio Gerosa, Gino Iliceto, Sabino Motta, Raffaella |
author_facet | Pergola, Valeria Mattesi, Giulia Cozza, Elena Pradegan, Nicola Tessari, Chiara Dellino, Carlo Maria Savo, Maria Teresa Amato, Filippo Cecere, Annagrazia Perazzolo Marra, Martina Tona, Francesco Guaricci, Andrea Igoren De Conti, Giorgio Gerosa, Gino Iliceto, Sabino Motta, Raffaella |
author_sort | Pergola, Valeria |
collection | PubMed |
description | Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and non-invasive imaging techniques, certain aspects such as the timing of echocardiographic assessments and the role of echocardiography or cardiac magnetic resonance (CMR) as alternatives to serial endomyocardial biopsies (EMBs) for rejection monitoring are not specifically outlined in the guidelines. Furthermore, invasive coronary angiography (ICA) is still recommended as the gold-standard procedure, usually performed one year after surgery and every two years thereafter. This review focuses on recent advancements in non-invasive and contrast-saving imaging techniques that have been investigated for HT patients. The aim of the manuscript is to identify imaging modalities that may potentially replace or reduce the need for invasive procedures such as ICA and EMB, considering their respective advantages and disadvantages. We emphasize the transformative potential of non-invasive techniques in elevating patient care. Advanced echocardiography techniques, including strain imaging and tissue Doppler imaging, offer enhanced insights into cardiac function, while CMR, through its multi-parametric mapping techniques, such as T1 and T2 mapping, allows for the non-invasive assessment of inflammation and tissue characterization. Cardiac computed tomography (CCT), particularly with its ability to evaluate coronary artery disease and assess graft vasculopathy, emerges as an integral tool in the follow-up of HT patients. Recent studies have highlighted the potential of nuclear myocardial perfusion imaging, including myocardial blood flow quantification, as a non-invasive method for diagnosing and prognosticating CAV. These advanced imaging approaches hold promise in mitigating the need for invasive procedures like ICA and EMB when evaluating the benefits and limitations of each modality. |
format | Online Article Text |
id | pubmed-10487200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104872002023-09-09 New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options Pergola, Valeria Mattesi, Giulia Cozza, Elena Pradegan, Nicola Tessari, Chiara Dellino, Carlo Maria Savo, Maria Teresa Amato, Filippo Cecere, Annagrazia Perazzolo Marra, Martina Tona, Francesco Guaricci, Andrea Igoren De Conti, Giorgio Gerosa, Gino Iliceto, Sabino Motta, Raffaella Diagnostics (Basel) Review Heart transplantation (HT) is the established treatment for end-stage heart failure, significantly enhancing patients’ survival and quality of life. To ensure optimal outcomes, the routine monitoring of HT recipients is paramount. While existing guidelines offer guidance on a blend of invasive and non-invasive imaging techniques, certain aspects such as the timing of echocardiographic assessments and the role of echocardiography or cardiac magnetic resonance (CMR) as alternatives to serial endomyocardial biopsies (EMBs) for rejection monitoring are not specifically outlined in the guidelines. Furthermore, invasive coronary angiography (ICA) is still recommended as the gold-standard procedure, usually performed one year after surgery and every two years thereafter. This review focuses on recent advancements in non-invasive and contrast-saving imaging techniques that have been investigated for HT patients. The aim of the manuscript is to identify imaging modalities that may potentially replace or reduce the need for invasive procedures such as ICA and EMB, considering their respective advantages and disadvantages. We emphasize the transformative potential of non-invasive techniques in elevating patient care. Advanced echocardiography techniques, including strain imaging and tissue Doppler imaging, offer enhanced insights into cardiac function, while CMR, through its multi-parametric mapping techniques, such as T1 and T2 mapping, allows for the non-invasive assessment of inflammation and tissue characterization. Cardiac computed tomography (CCT), particularly with its ability to evaluate coronary artery disease and assess graft vasculopathy, emerges as an integral tool in the follow-up of HT patients. Recent studies have highlighted the potential of nuclear myocardial perfusion imaging, including myocardial blood flow quantification, as a non-invasive method for diagnosing and prognosticating CAV. These advanced imaging approaches hold promise in mitigating the need for invasive procedures like ICA and EMB when evaluating the benefits and limitations of each modality. MDPI 2023-08-31 /pmc/articles/PMC10487200/ /pubmed/37685356 http://dx.doi.org/10.3390/diagnostics13172818 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pergola, Valeria Mattesi, Giulia Cozza, Elena Pradegan, Nicola Tessari, Chiara Dellino, Carlo Maria Savo, Maria Teresa Amato, Filippo Cecere, Annagrazia Perazzolo Marra, Martina Tona, Francesco Guaricci, Andrea Igoren De Conti, Giorgio Gerosa, Gino Iliceto, Sabino Motta, Raffaella New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title | New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title_full | New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title_fullStr | New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title_full_unstemmed | New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title_short | New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options |
title_sort | new non-invasive imaging technologies in cardiac transplant follow-up: acquired evidence and future options |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487200/ https://www.ncbi.nlm.nih.gov/pubmed/37685356 http://dx.doi.org/10.3390/diagnostics13172818 |
work_keys_str_mv | AT pergolavaleria newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT mattesigiulia newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT cozzaelena newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT pradegannicola newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT tessarichiara newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT dellinocarlomaria newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT savomariateresa newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT amatofilippo newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT cecereannagrazia newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT perazzolomarramartina newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT tonafrancesco newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT guaricciandreaigoren newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT decontigiorgio newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT gerosagino newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT ilicetosabino newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions AT mottaraffaella newnoninvasiveimagingtechnologiesincardiactransplantfollowupacquiredevidenceandfutureoptions |